Dr. Robert Lodder
Dr. Robert Lodder


Dr. Lodder received his B.S. degree in Natural Science, along with a M.S. in Chemistry, from Xavier University in 1981 and 1983. He received his Ph.D. in Analytical Chemistry in 1988 after working with Professor Gary M. Hieftje at Indiana University. Dr. Lodder holds joint appointments as a professor in the Department of Electrical and Computer Engineering, and the Division of Analytical Chemistry of the Department of Chemistry at Kentucky. He serves on the board of directors of Spherix (Nasdaq: SPEX), as editor in chief of the astroanalytical chemistry and astrobiology journal Contact in Context, and as a member of the U.S. Food and Drug Administration Advisory Committee on Pharmaceutical Science, Process Analytical Technologies subcommittee. Dr. Lodder is a first-prize winner in the 1990 international IBM Supercomputing Competition, as well as a winner of a National Science Foundation Young Investigator Award, the American Society of Agricultural Engineers Paper Award, a Buchi NIR Award, the Tomas Hirschfeld Award in Near-IR Spectroscopy (PittCon), a Research and Development 100 Award, and the Orville N. Green Service Award (SETICon).


  • Clinical trials
  • hyperspectral imaging
  • infectious disease
  • pediatric disease
  • high performance computing

Recent Publications

  • Lodder Robert A. (2016). 4-Week Toxicity And Toxicokinetic Oral Gavage Study With Polydatin In Rats. WedMedCentral TOXICOLOGY, 7(11),
  • Lodder Robert A. (2016). Effect of BSN272 on Hyperlipidemia and Atherosclerosis in LDLr -/- Mice. WebMedCentral PHARMACEUTICAL SCIENCES, 7(11),
  • Lodder Robert A. (2016). Toward Surreptitious Remote Sensing of Blood Alcohol Concentration: Results with Integrated Near-Infrared Spectral Imaging and Laser Speech Detection. WebMedCentral ALCOHOLISM, 7(10),
  • Lodder Robert A, Ensor Charles, Banfield Amy. (2015). BSN272 Prevents Western Diet-Induced Atherosclerosis and Excess Weight Gain in ApoE/Mice. WebMedCentral ATHEROSCLEROSIS, 6(12),
  • Lodder Robert, Smith Rebecca. (2015). It’s Good to be an Orphan. J. Dev. Drugs., 4(4), 1065.
  • Ensor Mark, Banfield Amy B, Smith Rebecca R, Williams Jarrod, Lodder Robert A. (2015). Safety and efficacy of d-tagatose in glycemic control in subjects with type 2 diabetes. Journal of endocrinology, diabetes & obesity, 3(1),
  • Ensor Mark, Banfield Amy, Lodder Robert A. (2015). BSN272 Prevents Western Diet-Induced Atherosclerosis and Excess Weight Gain in ApoE/Mice. WebMedCentral ATHEROSCLEROSIS, 6(11),
  • Ensor Mark, Williams Jarrod, Smith Rebecca, Banfield Amy, Lodder Robert. (2014). Effects of Three Low-Doses of D-Tagatose on Glycemic Control over Six Months in Subjects with Mild Type 2 Diabetes Mellitus under Control with Diet and Exercise. J Endocrinol Diabetes Obes, 2(4), 1057-1068.
  • Metts B, Thatcher Sean Eric, Lewis E, Karounos M, LA Cassis R Smith, Lodder Robert A. (2013). DDDAS, Design of drug intervention for the treatment of dyslipidemia in ApoE-/- mice. J Develop Drugs , 2(2), 1-7.
  • Smith R R, Lodder Robert A. (2013). When does a Nanotechnology Device Become a Drug? Size Versus Smarts. J Develop Drugs , 2(e121),